Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone 0.01% Solution for Oral Lichen Planus
NCT00111072Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- May 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in oral lichen planus (OLP) comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Visual Analog Scale for Pain at 4 weeks. Started May 2005; status: completed.
02
Drugs
dexamethasone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT00111072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111072.